HCV has been classified into no fewer than six major genotypes and a series of subtypes. Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution, and response to therapy. Genotypes 1, 2, and 3 are common throughout North America and Europe. HCV genotype 4 (HCV-4) is common in the Middle East and in Africa, where it is responsible for more than 80% of HCV infections. It has recently spread to several European countries. HCV-4 is considered a major cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions. Although HCV-4 is the cause of approximately 20% of the 170 million cases of chronic hepatitis C in the world, it has not been the subject of widespread research. Therefore, this document, drafted by a panel of international experts, aimed to review current knowledge on the epidemiology, natural history, clinical, histological features, and treatment of HCV-4 infections.
Management of hepatitis C virus genotype 4: recommendations of an international expert panel / M.A. Khattab, P. Ferenci, S.J. Hadziyannis, M. Colombo, M.P. Manns, P.L. Almasio, R. Esteban, A.A. Abdo, S.A. Harrison, N. Ibrahim, P. Cacoub, M. Eslam, S.S. Lee. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 54:6(2011 Jun), pp. 1250-1262.
|Titolo:||Management of hepatitis C virus genotype 4: recommendations of an international expert panel|
|Settore Scientifico Disciplinare:||Settore MED/12 - Gastroenterologia|
|Data di pubblicazione:||giu-2011|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/j.jhep.2010.11.016|
|Appare nelle tipologie:||01 - Articolo su periodico|